Literature DB >> 18424210

OPHDIAT: quality-assurance programme plan and performance of the network.

A Erginay1, A Chabouis, C Viens-Bitker, N Robert, A Lecleire-Collet, P Massin.   

Abstract

AIMS: There is a need for evaluation of screening and grading services for diabetic retinopathy (DR) in compliance with quality-assurance (QA) standards. We describe the screening/grading QA programme set up for OPHDIAT over the 2005-2006 period.
METHODS: Screening and grading objectives, evaluation criteria and minimum acceptable QA standards were set. To ensure the quality of DR photos, the proportion of nongradable photos in at least one eye had to be less than 10%. To ensure grading accuracy, intergrading agreement had to be greater than 90%. Grader-generated reports had to be available in less than 48 h for more than 80% photos. Readers had to grade 500 to 3000 photos per year.
RESULTS: Sixteen screening centres were opened between June 2004 and December 2006, and 14,769 patients were screened. Percentages of nongradable photos were consistently below the QA requirement (less than 10%). Overall, 800 photos were graded a second time by a reader blinded to original grading; agreement between graders ranged from 92 to 99%. More than 90% of grader-generated reports were produced within 48 h. The number of readings by each grader nearly achieved the QA standard.
CONCLUSION: QA for DR telescreening should be a continuous process to provide performance feedback, thus guaranteeing a high standard for delivered results. Almost all of the predetermined QA standards in OPHDIAT for screening and grading were met. Besides the quality/sensitivity of the screening/grading modalities, it is important to evaluate at-risk patients so that they can be treated efficiently; this should be addressed in a global QA programme.

Entities:  

Mesh:

Year:  2008        PMID: 18424210     DOI: 10.1016/j.diabet.2008.01.004

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  6 in total

1.  Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs.

Authors:  Kevin Tozer; Maria A Woodward; Paula A Newman-Casey
Journal:  J Endocrinol Diabetes       Date:  2015-11-11

2.  Assessing the Quality of Teleconsultations in a Store-And-Forward Telemedicine Network - Long-Term Monitoring Taking into Account Differences between Cases.

Authors:  Richard Wootton; Joanne Liu; Laurent Bonnardot
Journal:  Front Public Health       Date:  2014-10-28

3.  Experience with Quality Assurance in Two Store-and-Forward Telemedicine Networks.

Authors:  Richard Wootton; Joanne Liu; Laurent Bonnardot; Raghu Venugopal; Amanda Oakley
Journal:  Front Public Health       Date:  2015-11-26

4.  Assessment of Training Outcomes of Nurse Readers for Diabetic Retinopathy Telescreening: Validation Study.

Authors:  Marie Carole Boucher; Michael Trong Duc Nguyen; Jenny Qian
Journal:  JMIR Diabetes       Date:  2020-04-07

5.  Assessing the quality of teleconsultations in a store-and-forward telemedicine network.

Authors:  Richard Wootton; Joanne Liu; Laurent Bonnardot
Journal:  Front Public Health       Date:  2014-07-16

6.  Suitability of a Low-Cost, Handheld, Nonmydriatic Retinograph for Diabetic Retinopathy Diagnosis.

Authors:  Gwenolé Quellec; Loïc Bazin; Guy Cazuguel; Ivan Delafoy; Béatrice Cochener; Mathieu Lamard
Journal:  Transl Vis Sci Technol       Date:  2016-04-20       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.